 that the FDA should have approved a particular drug. So it really is going to have potentially really wide-ranging implications. The majority tried to downplay the potential effect of the ruling. It said, we, the Supreme Court, have not actually relied on this Chevron doctrine since 2016. But thousands of lower court decisions have relied on that. So it's something that we may not see it play out in our day-to-day lives.